These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients. Reimherr FW, Cunningham LA, Batey SR, Johnston JA, Ascher JA. Clin Ther; 1998 Dec; 20(3):505-16. PubMed ID: 9663366 [Abstract] [Full Text] [Related]
3. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. Bennie EH, Mullin JM, Martindale JJ. J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364 [Abstract] [Full Text] [Related]
4. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA. Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731 [Abstract] [Full Text] [Related]
16. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody D. J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924 [Abstract] [Full Text] [Related]
17. A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice. Doogan DP, Langdon CJ. Int Clin Psychopharmacol; 1994 Jan; 9(2):95-100. PubMed ID: 8057000 [Abstract] [Full Text] [Related]